CELG - Celgene Corp.

CELG valuation $95.17 billion

Stock Price

Change: ↓ -1.71 (-1.4147%)
Last Update: 2015-01-30T16:15:19-05:00
Shares Outstanding: 798,704,188
Industry: Biotechnology
Website Investor Relations

Celgene is an American biotechnology company. The main areas of Celgene’s work include creating solutions for inflammatory disorders and cancer. Some of the most popular products the company produces include Thalomid and Revlimid. The organization was initially founded as a sub-unit of the Celanese Corporation, but eventually emerged as an independent company after Celanese Corporation merged with American Hoechst Corporation.

Celgene is among the most prestigious biotechnology companies in the world and is not only listed in the NASDAQ stock market but is also a member of NASDAQ-100 and S&P 500. In 2012, the company was reported to provide employment to over 4,000 people. Over the years, Celgene has acquired different pharmaceutical companies, among which the most prominent ones are:

  1. Pharmion Corporation
  2. Gloucester Pharmaceuticals
  3. Anthrogenesis

The organization has its offices spread across the globe and also has a subsidiary company called Celgene Cellular Therapeutics, which is a public cord blood bank. In the recent years, the organization has faced legal challenges as well as political criticism. When the company became part of the Americans Legislative Exchange Council (ALEC), it was greatly criticized by students, labor unions and community groups. However, the company enjoys annual revenues of over $4 billion.

Stock Price Data

Open: 119.49 Previous Close: 120.87
High: 124.29 Low: 118.89
Bid: 119.18 Ask: 120.21

Bid Size: 100 Ask Size: 1000
Raw Bid Size: 1 Raw Ask Size: 10
Trade Volume: 52765 Share Volume: 7814138
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:03-05:00
Vwap: 120.8382628 EPS: 1.92

Fundamental Data

PE ratio: 63.10 PB ratio: 16.504
Beta: 1.08983

52 Week High: 124.60 52 Week Low: 66.85
52 Week High Vwap: 123.8152 52 Week Low Vwap: 66.1772
52 Week High Volume: 18996884 52 Week Low Volume: 2521148
52 Week Avg Volume: 5658692
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29